Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|May 20, 2021
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid LeukemiaNoortje van Gils, Fedor Denkers, Linda Smit
Experimental Hematology|May 1, 2017
Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiationNoortje van Gils, Han J M P Verhagen, Linda Smit
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid ReceptorsMarjolein Soethoudt, Noortje van Gils, Mario van der Stelt, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 24, 2022
Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2Jara Bouma, Marjolein Soethoudt, Noortje van Gils, et al.
Nature Communications|January 19, 2017
Structural basis of ligand interaction with atypical chemokine receptor 3Martin Gustavsson, Liwen Wang, Noortje van Gils, et al.
Leukemia|February 15, 2023
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionMargot F van Spronsen, Diana Hanekamp, Theresia M Westers, et al.
Blood Advances|December 22, 2020
IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cellsNoortje van Gils, Han J M P Verhagen, Arjo Rutten, et al.
British Journal of Pharmacology|September 24, 2015
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicityPartha Mukhopadhyay, Marc Baggelaar, Katalin Erdelyi, et al.
Pageof 2